Related Experiment Video
Updated: Jun 12, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Bone mineral density in HIV-infected women taking antiretroviral therapy: a systematic review
Erico Higino de Carvalho1, Thais Gelenske, Francisco Bandeira
1Instituto de Medicina Integral Professor Fernando Figueira, Recife, PE, Brasil. ericohc@hotmail.com <ericohc@hotmail.com>
Insights
Antiretroviral therapy (ART) is linked to lower bone mineral density (BMD) at the femoral neck in HIV-positive women. More research is needed to understand osteoporosis and fracture risks in this population.
Area of Science:
- Medical Science
- Infectious Diseases
- Bone Health
Background:
- Osteoporosis is common in HIV-infected individuals, affecting both men and women.
- Antiretroviral therapy (ART) is suspected to contribute to osteoporosis development in HIV patients.
- The specific impact of ART on bone health and fracture risk in HIV-positive women remains unclear.
Purpose of the Study:
- To systematically review the literature on bone loss, bone mineral density (BMD), and fractures in HIV-positive women using ART or protease inhibitors (PI).
Main Methods:
- A systematic review of five studies was conducted after screening 597 citations from PubMed, EMBASE, and Lilacs.
- The review focused on evaluating BMD and fracture data in HIV-positive women on ART/PI therapy.
Main Results:
- A significant difference of over 3% in femoral neck BMD was observed in HIV-positive women using PI/ART compared to non-users.
- No significant difference in lumbar spine BMD was found between ART/PI users and non-users.
- Insufficient data prevented conclusions regarding fracture occurrence in this cohort.
Conclusions:
- PI/ART use is associated with reduced femoral neck BMD in HIV-positive women.
- Further research is essential to elucidate the relationship between ART, osteoporosis, and fracture risk in HIV-positive women.
Abstract:
There is a high prevalence of osteoporosis in HIV-infected patients. Initially described in HIV-positive men, studies have also demonstrated a high prevalence of osteoporosis in HIV-infected women. It would appear that antiretroviral therapy (ART) plays an important role in the pathogenesis of osteoporosis in HIV-infected patients, although little is known about its importance in relation to osteoporosis and fractures in HIV-positive women. The aim of this systematic review was to evaluate the frequency of bone loss, bone mineral density (BMD) and fractures in HIV-positive women taking ART or protease inhibitors (PI). After screening 597 citations from the databases of PubMed, EMBASE and Lilacs, five studies were selected for the review. A difference was demonstrated of over 3% in the BMD at the femoral neck of HIV-positive women taking PI/ART. No difference was registered in the BMD at the lumbar spine between users and non-users of PI/ART. The lack of studies has made it impossible to reach any conclusion regarding the occurrence of fractures.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Sexually Transmitted Infections
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
